Literature DB >> 20119723

MR imaging findings suggestive of posterior reversible encephalopathy syndrome in adolescents with systemic lupus erythematosus.

Eyal Muscal1, Elfrides Traipe, Marietta M de Guzman, Barry L Myones, Robin L Brey, Jill V Hunter.   

Abstract

BACKGROUND: Endothelial damage, hypertension and cytotoxic medications may serve as risk factors for the posterior reversible encephalopathy syndrome (PRES) in systemic lupus erythematosus. There have been few case reports of these findings in pediatric lupus patients.
OBJECTIVE: We describe clinical and neuroimaging findings in children and adolescents with lupus and a PRES diagnosis.
MATERIALS AND METHODS: We identified all clinically acquired brain MRIs of lupus patients at a tertiary care pediatric hospital (2002-2008). We reviewed clinical features, conventional MRI and diffusion-weighted imaging (DWI) findings of patients with gray- and white-matter changes suggestive of vasogenic edema and PRES.
RESULTS: Six pediatric lupus patients presenting with seizures and altered mental status had MRI findings suggestive of PRES. In five children clinical and imaging changes were seen in conjunction with hypertension and active renal disease. MRI abnormalities were diffuse and involved frontal regions in five children. DWI changes reflected increased apparent diffusivity coefficient (unrestricted diffusion in all patients). Clinical and imaging changes significantly improved with antihypertensive and fluid management.
CONCLUSION: MRI changes suggestive of vasogenic edema and PRES may be seen in children with active lupus and hypertension. The differential diagnosis of seizures and altered mental status should include PRES in children, as it does in adults.

Entities:  

Mesh:

Year:  2010        PMID: 20119723     DOI: 10.1007/s00247-009-1540-y

Source DB:  PubMed          Journal:  Pediatr Radiol        ISSN: 0301-0449


  19 in total

Review 1.  Posterior reversible encephalopathy syndrome, part 2: controversies surrounding pathophysiology of vasogenic edema.

Authors:  W S Bartynski
Journal:  AJNR Am J Neuroradiol       Date:  2008-04-10       Impact factor: 3.825

Review 2.  Neuropsychiatric lupus: clinical and imaging aspects.

Authors:  Robin L Brey
Journal:  Bull NYU Hosp Jt Dis       Date:  2007

3.  Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus.

Authors:  M C Hochberg
Journal:  Arthritis Rheum       Date:  1997-09

Review 4.  The American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes.

Authors: 
Journal:  Arthritis Rheum       Date:  1999-04

5.  The relationship between initial clinical manifestation and long-term prognosis of patients with systemic lupus erythematosus.

Authors:  Yoshiaki Tokano; Shinji Morimoto; Hirofumi Amano; Toshiaki Kawanishi; Tetsuro Yano; Masayuki Tomyo; Masahiro Sugawara; Shigeto Kobayashi; Hiroshi Tsuda; Yoshinari Takasaki; Hiroshi Hashimoto
Journal:  Mod Rheumatol       Date:  2005       Impact factor: 3.023

Review 6.  Reversible posterior leukoencephalopathy in patients with systemic lupus erythematosus.

Authors:  Molly D Magnano; Thomas M Bush; Ivonne Herrera; Roy D Altman
Journal:  Semin Arthritis Rheum       Date:  2006-06       Impact factor: 5.532

Review 7.  Posterior reversible encephalopathy syndrome: an emerging clinical entity in adult, pediatric, and obstetric critical care.

Authors:  Heather O'Hara McCoy
Journal:  J Am Acad Nurse Pract       Date:  2008-02

8.  Posterior reversible encephalopathy syndrome as a complication of acute lupus activity.

Authors:  José Fidel Baizabal-Carvallo; Héctor Manuel Barragán-Campos; Héctor Javier Padilla-Aranda; Marlene Alonso-Juarez; Bruno Estañol; Carlos Cantú-Brito; Guillermo García-Ramos
Journal:  Clin Neurol Neurosurg       Date:  2009-01-06       Impact factor: 1.876

9.  Prevalence of and annual ambulatory health care visits for pediatric arthritis and other rheumatologic conditions in the United States in 2001-2004.

Authors:  Jeffrey J Sacks; Charles G Helmick; Yao-Hua Luo; Norman T Ilowite; Suzanne Bowyer
Journal:  Arthritis Rheum       Date:  2007-12-15

10.  Reversible posterior leuko-encephalopathy in children with sickle cell disease.

Authors:  Zarir Khademian; Barbara Speller-Brown; Seyed-Medhi Nouraie; Caterina P Minniti
Journal:  Pediatr Blood Cancer       Date:  2009-03       Impact factor: 3.167

View more
  2 in total

1.  The spectrum of posterior reversible encephalopathy in systemic lupus erythematosus.

Authors:  Amritha Budhoo; Girish M Mody
Journal:  Clin Rheumatol       Date:  2015-08-23       Impact factor: 2.980

Review 2.  The multifactorial origin of posterior reversible encephalopathy syndrome in cyclophosphamide-treated lupus patients.

Authors:  Tatjana Zekić; Mirjana Stanić Benić; Ronald Antulov; Igor Antončić; Srđan Novak
Journal:  Rheumatol Int       Date:  2017-10-17       Impact factor: 2.631

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.